Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of prior AVP vaccination timing on immune response to AVP booster
2005-004833-17Phase 4Completed
- Sponsor
- Defence Science and Technology Laboratory
- Start
- Jun 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of anthrax vaccine adsorbed in anthrax (2 arms), sponsored by Defence Science and Technology Laboratory. Primary endpoints: Antibody concentration response after AVP booster, Serum toxin neutralization response after AVP booster and 1 more. Started Jun 2007; status: completed.
02
Drugs
anthrax vaccine adsorbed
03
Conditions
anthrax
Beyond the preview
Go deeper on 2005-004833-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004833-17.